Industry News
Scientists discover link between bacteria and supposedly non-infectious diseases
9/07/2016
A group of scientists have found that a single molecule from a bacterial cell wall component can lead to the unusual behaviour of 100 million clotting molecules in blood, which may be a major...
Nanotechnology supports treatment of malignant melanoma
9/07/2016
Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology.
Two studies appearing in JAMA examine the effectiveness of nasal sprays to reduce the frequency and duration of nosebleeds caused by hereditary hemorrhagic telangiectasia (HHT), an inherited...
Hypertension: Releasing the pressure at its source
9/07/2016
Researchers eyeing first new anti-hypertensive drug treatment strategy in more than 15 years.
NCI embraces scientific road map to achieve Cancer Moonshot goals
9/06/2016
National Cancer Institute Acting Director Douglas Lowy, M.D., today accepted, with revisions that reflect NCAB’s discussion, the recommendations of a Blue Ribbon Panel (BRP) on 10 approaches most likely to make a decade’s worth of progress against cancer in five years, a key goal of the White House Cancer Moonshot.
Enlarged prostate: Molecular mechanism clue may explain link to inflammation
9/06/2016
Discovery of molecular mechanism may explain how inflammation leads to benign prostatic hyperplasia and improve response to androgen-targeted therapies.
Aberrant epigenetic regulation behind the intestinal symptoms in coeliac disease
9/06/2016
Researchers at the University of Tampere discovered a mechanism causing aberrancies in coeliac disease and colorectal cancer.
Melanoma and the microenvironment - Age matters
9/06/2016
Advancing age is a risk factor for cancer, and there is no doubt that the accumulation of DNA damage over time contributes to the correlation of age with cancer risk: an increase in the number of...
A gene defect as a potential gateway for targeted prostate cancer therapy
9/06/2016
The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors.
Biobank storage time affects blood test results
9/06/2016
The amount of time a blood sample used for medical research has been stored at a biobank may affect the test results as much as the blood sample provider's age.